Calcium Carbonate + Sodium Alginate + Sodium Bicarbonate
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Calcium Carbonate
calcium-carbonate - Sodium Alginate
sodium-alginate - Sodium Bicarbonate
sodium-bicarbonate
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Gaviscon Peppermint TabletsAUSGTW | 250 mg / 133.5 mg / 80 mg | RECKITT BENCKISER (SINGAPORE) PTE LTD |
| GAVISCON DOUBLE ACTION LIQUID, SUSPENSIONHKSG | 325 mg / 500 mg / 213 mg | RECKITT BENCKISER (SINGAPORE) PTE LTD |
| GAVISCON LIQUIDHKSG | 160 mg / 500 mg / 267 mg | RECKITT BENCKISER (SINGAPORE) PTE LTD |
| Gaviscon Original Aniseed ReliefGB | 250 mg / 133.5 mg / 80 mg | Reckitt Benckiser |
| Gaviscon Dual Action Peppermint LiquidAU | 500 mg / 213 mg / 325 mg | Reckitt Benckiser |
| Gaviscon Dual Action Mixed Berry LiquidAU | 500 mg / 213 mg / 325 mg | Reckitt Benckiser |
| Gaviscon Dual Action Peppermint Liquid SachetsAU | 500 mg / 213 mg / 325 mg | Reckitt Benckiser |
| Gaviscon Peppermint LiquidAU | 500 mg / 267 mg / 160 mg | Reckitt Benckiser |
| GAVISCON DUAL ACTION LIQUID SACHETS oral liquid suspension sachetAU | 32.5 mg / 50 mg / 21.3 mg | Reckitt Benckiser Pty Ltd |
| Copy of GAVISCON DUAL ACTION peppermint flavour oral liquid bottleAU | 32.5 mg / 50 mg / 21.3 mg | Reckitt Benckiser Pty Ltd |
| GAVISCON DUAL ACTION mixed berry flavour oral liquid bottleAU | 32.5 mg / 50 mg / 21.3 mg | Reckitt Benckiser Pty Ltd |
| GAVISCON EXTRA STRENGTH peppermint flavour chewable tablet blister packAU | 160 mg / 500 mg / 267 mg | Reckitt Benckiser Pty Ltd |
| GAVISCON EXTRA STRENGTH peppermint flavour chewable tablet bottleAU | 160 mg / 500 mg / 267 mg | Reckitt Benckiser Pty Ltd |
| GAVISCON peppermint flavour chewable tablet (reformulation 3) blister packAU | 80 mg / 250 mg / 133.5 mg | Reckitt Benckiser Pty Ltd |
| GAVISCON aniseed flavour oral liquid bottleAU | 16 mg / 50 mg / 26.7 mg | Reckitt Benckiser Pty Ltd |
| GASCOVID LIQUIDSG | 160 mg / 500 mg / 267 mg | GOLDPLUS UNIVERSAL PTE LTD |
| GAVISCON DOUBLE ACTION TABLETSSG | 187.5 mg / 250 mg / 106.5 mg | RECKITT BENCKISER (SINGAPORE) PTE LTD |
| GAVISCON DOUBLE ACTION CHEWABLE TABHK | — | RECKITT BENCKISER HONG KONG LTD |
| GAVISCON EXTRA STRENGTH 500 PEPPERMINT CHEWABLE TABHK | — | RECKITT BENCKISER HONG KONG LTD |
| GAVISCON LIQUID (PEPPERMINT)HK | — | RECKITT BENCKISER HONG KONG LTD |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.